Seroquel

Seroquel Side Effects
Schizophrenia drug

Seroquel, the popular schizophrenia drug, has been linked to a higher incidence of diabetes. Data from a recent medical conference in Philadelphia showed patients on Seroquel had 33.4 times as many cases of diabetes as those on older antipsychotic medications.

Seroquel has been linked to a high incidence of type 2 diabetes, hyperglycemia and other blood sugar disorders. Data from a 2003 study, reported at the international society from pharmacoepidemiology conference, suggests that patients taking Seroquel had 33.4 times as many cases of diabetes as those on older antipsychotic drugs. The FDA issued a Med Watch safety alert concerning the increased risk of hyperglycemia and diabetes in patients taking Seroquel.

Seroquel has also been linked to pancreatitis. Pancreatitis is a dangerous inflammation of the pancreas. The pancreas secretes digestive enzymes into the small intestine that help digest fats, proteins, and carbohydrates in food. The pancreas also releases the hormones insulin and glucagon into the bloodstream that help the body use the glucose it takes from food for energy.

The Joel Bieber Firm is currently evaluating potential Seroquel lawsuits. If you believe you have suffered an injury from this prescribed medication, please fill out the form below which will help start the process for our Seroquel lawyers.

Take the Seroquel Survey

Case Information

If you can answer YES to any of the following Seroquel side effects, place a checkmark in the boxes below that are applicable.

Type II Diabetes   Hyperglycemia   Blood Sugar Disorders  Pancreatitis

Date of Diagnosis:     

During what period of time was Seroquel prescribed?

Why was Seroquel prescribed?

Other medications while taking Seroquel:

Please place a checkmark in the boxes below that are applicable.

Diagnosis of Diabetes? If checked, select one:
      Before Seroquel
      After Seroquel

Diagnosis of Hyperglycemia?  
      Before Seroquel
      After Seroquel

Diagnosis of Pancreatitis?  
      Before Seroquel
      After Seroquel

Please give any other details related to your experience with Seroquel:

Contact Information
* Indicates a required field.

* Your Name:
   Mr. Mrs. Ms. Dr.
Marital Status:
   Single Married  Divorced Separated Widowed
* Address:
  
* City:
  
County:
  
* State:
  
* Zip:
  
* Home Phone:
  
Work Phone:
  
Cell Phone:
  
* E-mail:
  
* SPAM CHECK:
  

Please type the numbers 1, 2, and 3
in the field above using no commas and no spaces
* Yes, I have read and agree to the Joel Bieber Firm disclaimer

Please review your information before sending.

** Electronic Form Submissions

The mere submission of a contact form does not necessarily form an attorney-client relationship with the Joel Bieber Firm. However, if my case is evaluated and I receive a response from the firm, I understand that an attorney-client relationship will be formed. If I do not receive a response, my case was not evaluated; hence an attorney client relationship has not been formed.

If you send us information electronically via this website, you agree that our review of that information, even if you submitted it in a good faith effort to retain us, and, further, even if it is highly confidential, does not preclude us from representing another client directly adverse to you, even in a matter where that information could and will be used against you.

I agree that the information that I will receive in response to the above question is general information and I will not be charged for the response to this e-mail question. I further understand that the law for each state may vary, and therefore, I will not rely upon this information as legal advice. Due to the reach of the internet, this matter may require advice regarding my home state; I agree that local counsel may be contacted for referral of this matter.

I understand that additional disclaimer information is viewable under the disclaimer headline (Terms of Use & Privacy Policy) of this website.

Seroquel News - headlines from around the web on July 4, 2009

Return to the Homepage